These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28289407)

  • 1. A Novel Antimicrobial Endolysin, LysPA26, against
    Guo M; Feng C; Ren J; Zhuang X; Zhang Y; Zhu Y; Dong K; He P; Guo X; Qin J
    Front Microbiol; 2017; 8():293. PubMed ID: 28289407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
    Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
    Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kim S; Lee DW; Jin JS; Kim J
    J Glob Antimicrob Resist; 2020 Sep; 22():32-39. PubMed ID: 32006750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity.
    Yuan Y; Li X; Wang L; Li G; Cong C; Li R; Cui H; Murtaza B; Xu Y
    Microb Biotechnol; 2021 Mar; 14(2):403-418. PubMed ID: 32519416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PlyKp104, a Novel Phage Lysin for the Treatment of Klebsiella pneumoniae, Pseudomonas aeruginosa, and Other Gram-Negative ESKAPE Pathogens.
    Euler CW; Raz A; Hernandez A; Serrano A; Xu S; Andersson M; Zou G; Zhang Y; Fischetti VA; Li J
    Antimicrob Agents Chemother; 2023 May; 67(5):e0151922. PubMed ID: 37098944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel
    Khan FM; Gondil VS; Li C; Jiang M; Li J; Yu J; Wei H; Yang H
    Front Cell Infect Microbiol; 2021; 11():637313. PubMed ID: 33738267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of endolysin across outer membrane of Gram-negative bacteria using translocation domain of botulinum neurotoxin.
    Park W; Park M; Chun J; Hwang J; Kim S; Choi N; Kim SM; Kim S; Jung S; Ko KS; Kweon DH
    Int J Antimicrob Agents; 2024 May; 64(2):107216. PubMed ID: 38795926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal Effect of Cecropin A Fused Endolysin on Drug-Resistant Gram-Negative Pathogens.
    Lim J; Hong J; Jung Y; Ha J; Kim H; Myung H; Song M
    J Microbiol Biotechnol; 2022 Jun; 32(6):816-823. PubMed ID: 35586934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial Activity of a Lytic Enzyme Encoded by
    Yang Y; Le S; Shen W; Chen Q; Huang Y; Lu S; Tan Y; Li M; Hu F; Li Y
    Front Microbiol; 2018; 9():1778. PubMed ID: 30127777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Analysis of a Novel Phage Infecting the Turkey Pathogen
    Deng S; Xu Q; Fu Y; Liang L; Wu Y; Peng F; Gao M
    Viruses; 2021 May; 13(6):. PubMed ID: 34072620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and expression analysis of fused holin-endolysin from RL bacteriophage; Exhibits broad activity against multi drug resistant pathogens.
    Basit A; Qadir S; Qureshi S; Rehman SU
    Enzyme Microb Technol; 2021 Sep; 149():109846. PubMed ID: 34311883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial.
    Giammanco A; CalĂ  C; Fasciana T; Dowzicky MJ
    mSphere; 2017; 2(1):. PubMed ID: 28124025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogens.
    Briers Y; Walmagh M; Van Puyenbroeck V; Cornelissen A; Cenens W; Aertsen A; Oliveira H; Azeredo J; Verween G; Pirnay JP; Miller S; Volckaert G; Lavigne R
    mBio; 2014 Jul; 5(4):e01379-14. PubMed ID: 24987094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and Enzymatic Characterization of ABgp46, a Novel Phage Endolysin with Broad Anti-Gram-Negative Bacterial Activity.
    Oliveira H; Vilas Boas D; Mesnage S; Kluskens LD; Lavigne R; Sillankorva S; Secundo F; Azeredo J
    Front Microbiol; 2016; 7():208. PubMed ID: 26955368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Salmonella endolysin XFII produced by recombinant Escherichia coli and its application combined with chitosan in lysing Gram-negative bacteria.
    Zhang S; Chang Y; Zhang Q; Yuan Y; Qi Q; Lu X
    Microb Cell Fact; 2022 Aug; 21(1):171. PubMed ID: 35999567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ts2631 Endolysin from the Extremophilic
    Plotka M; Kapusta M; Dorawa S; Kaczorowska AK; Kaczorowski T
    Viruses; 2019 Jul; 11(7):. PubMed ID: 31323845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial Activity of a Novel Peptide-Modified Lysin Against Acinetobacter baumannii and Pseudomonas aeruginosa.
    Yang H; Wang M; Yu J; Wei H
    Front Microbiol; 2015; 6():1471. PubMed ID: 26733995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of drug-resistant Acinetobacter baumannii by cell-penetrating peptide fused endolysin.
    Lim J; Jang J; Myung H; Song M
    J Microbiol; 2022 Aug; 60(8):859-866. PubMed ID: 35614377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of sensitizer peptide-fused endolysin Lys1S-L9P acting against multidrug-resistant gram-negative bacteria.
    Son SM; Kim J; Ryu S
    Front Microbiol; 2023; 14():1296796. PubMed ID: 38075915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial Activity of Stenotrophomonas maltophilia Endolysin P28 against both Gram-positive and Gram-negative Bacteria.
    Dong H; Zhu C; Chen J; Ye X; Huang YP
    Front Microbiol; 2015; 6():1299. PubMed ID: 26635765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.